<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02787811</url>
  </required_header>
  <id_info>
    <org_study_id>149</org_study_id>
    <nct_id>NCT02787811</nct_id>
  </id_info>
  <brief_title>Predictors of Success of IUI in Unexplained Infertility</brief_title>
  <official_title>Factors Affecting Success of IUI in Women With Unexplained Infertility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Superovulation will be conducted with 100 mg of oral clomiphene citrate (Clomifene; Young
      Poong Pharmaceutical, Incheon, Korea) for 5 days starting on day 3 of the menstrual cycle,
      followed by daily injection of 150 IU of human menopausal gonadotropin (hMG;Menogon;
      FerringPharamceutical Co, Germany). When more than 2 dominant follicles reached a diameter of
      17 mm or the urinary specimen showed positive results for luteinizing hormone (LH) surge,
      5000 IU of hCG (Pregnyl; Organon, Oss, the Netherlands) was injected intramuscularly.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Superovulation will conducted with 100 mg of oral clomiphene citrate (Clomifene; Young Poong
      Pharmaceutical, Incheon, Korea) for 5 days starting on day 3 of the menstrual cycle, followed
      by daily injection of 150 IU of human menopausal gonadotropin (hMG;Menogon;
      FerringPharamceutical Co, Germany). When more than 2 dominant follicles reached a diameter of
      17 mm or the urinary specimen showed positive results for luteinizing hormone (LH) surge,
      5000 IU of hCG (Pregnyl; Organon, Oss, the Netherlands) was injected intramuscularly.
      Successful pregnancy after IUI was confirmed by ultrasound as one or more visible gestational
      sacs in the uterine cavity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>chemical pregnancy rate</measure>
    <time_frame>14 days after IUI</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Assisted Reproductive Techniques</condition>
  <arm_group>
    <arm_group_label>Pregnant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>women with positive serum beta HCG done 14 days after Intrauterine insemenation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nonpregnant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>women with negative serum beta HCG done 14 days after Intrauterine insemenation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intrauterine insemenation</intervention_name>
    <description>Semen preparation processing hen intrauterine transfer after 24 hours of HCG triggering of ovulation</description>
    <arm_group_label>Pregnant</arm_group_label>
    <arm_group_label>Nonpregnant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  These patients had at least 1 tube patent

          -  there were no significant intrauterine or pelvic abnormalities demonstrated on
             pelvic-abdominal ultrasonography, hysteroscopy, and/or laparoscopy

          -  serum follicular stimulating hormone (FSH) level of12 mIU/mL or less

        Exclusion Criteria:

          -  A woman's age of more than 40 years,

          -  ovarian cyst detected in the ultrasound examination

          -  uterine lesions such as submucosal leiomyoma, and a previous diagnosis of moderate to
             severe pelvic endometriosis.

          -  women with body mass index &gt; 35 kg/m2,

          -  PCOS/anovulatory patients

          -  signs of hyperandrogenemia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Maged, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2016</study_first_submitted>
  <study_first_submitted_qc>May 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2016</study_first_posted>
  <last_update_submitted>March 18, 2017</last_update_submitted>
  <last_update_submitted_qc>March 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed Maged</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>IUI</keyword>
  <keyword>Pregnancy rate</keyword>
  <keyword>predictors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

